Preventive maintenance for two (2) macsquant multiparameter flow cytometers.
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00173
- Awardee
-
Miltenyi Biotec, Inc. UEI ZLDPMHA3M333
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $45,900
Award facts
- Contract value 100% obligated
- $45,900.00 Current and potential, with all options
- Completion date 57% complete
- Current and potential, with all options
- Funding agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $45.9K firm fixed-price purchase order to Miltenyi Biotec, Inc. for preventive maintenance services on two MACSQuant multiparameter flow cytometers. The contract was awarded on March 24, 2026, with an ultimate completion date of March 23, 2027, and will be performed at the National Cancer Institute's facility in Bethesda, Maryland. No set-aside designation was used in this procurement, reflecting Miltenyi Biotec's role as a specialized supplier of proprietary cytometry and cell analysis equipment for which alternative sources are limited.
Miltenyi Biotec, headquartered in Auburn, California, is a foreign-owned biotechnology equipment manufacturer specializing in cell separation, analysis, and processing technologies that support biomedical research and cell therapy development across the National Institutes of Health enterprise. The MACSQuant flow cytometry systems subject to this maintenance contract are critical analytical instruments utilized in the National Cancer Institute's research operations. This preventive maintenance award aligns with Miltenyi Biotec's extensive portfolio of federal contracts valued at millions of dollars, including a $4.6M indefinite delivery contract with the NIH Clinical Center for cell isolation reagents and consumables that supports Good Manufacturing Practice-compliant cell therapy manufacturing for over 50 clinical trials.
Quick answers
Who was awarded contract 75N98026P00173?
75N98026P00173 was awarded to Miltenyi Biotec, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on March 24, 2026.
How much is contract 75N98026P00173 worth?
The government has obligated $45,900 on 75N98026P00173.
Which agency awarded contract 75N98026P00173?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00173, with funding from National Cancer Institute (National Institutes of Health).
Was contract 75N98026P00173 competed?
The extent of competition for 75N98026P00173 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award